MACROGENICS INC (MGNX)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenues | 22,241 | 13,192 | 110,708 | 10,797 |
| Research and development | 40,791 | 39,698 | 40,543 | 51,732 |
| Selling, general and administrative | 9,302 | 10,718 | 14,104 | 14,423 |
| Cost of product sales | - | - | 168 | 176 |
| Cost of manufacturing services | 8,906 | 5,400 | 1,702 | 2,647 |
| Total costs and expenses | 58,999 | 55,816 | 56,517 | 68,978 |
| Loss from operations | -36,758 | -42,624 | 54,191 | -58,181 |
| Interest and other expense | 802 | 91 | - | 6 |
| Interest and other income | 1,414 | 1,679 | 2,118 | 2,523 |
| Loss before income taxes | -36,146 | - | - | - |
| Income tax provision | 105 | - | - | - |
| Net loss | -36,251 | -41,036 | 56,309 | -55,664 |
| Unrealized (loss) gain on investments | -6 | -5 | 38 | 11 |
| Comprehensive loss | -36,257 | -41,041 | 56,347 | -55,653 |
| Basic net loss per common share (in usd per share) | -0.57 | -0.65 | 0.9 | -0.89 |
| Basic weighted average common shares outstanding (in shares) | 63,136,057 | 62,965,415 | 62,744,005 | 62,663,677 |
| Diluted net loss per common share (in usd per share) | -0.57 | -0.65 | 0.9 | -0.89 |
| Diluted weighted average common shares outstanding (in shares) | 63,136,057 | 62,965,415 | 62,865,841 | 62,663,677 |